UQCRH Antibody

What is UQCRH and what is its biological significance?

UQCRH is a component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex (Complex III) that forms a crucial part of the mitochondrial electron transport chain driving oxidative phosphorylation. It functions as the hinge protein involved in the electron transfer reaction between cytochrome c1 and cytochrome c .

The respiratory chain contains three multisubunit complexes (Complex II, Complex III, and Complex IV) that cooperate to transfer electrons from NADH and succinate to molecular oxygen. This process creates an electrochemical gradient across the inner membrane that drives transmembrane transport and ATP synthase activity . Specifically, the cytochrome b-c1 complex (Complex III) catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to proton translocation across the mitochondrial inner membrane .

During the Q cycle, UQCRH helps facilitate a process where 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space, and 2 electrons are passed to cytochrome c .

How does UQCRH expression vary in different pathological conditions?

Research has revealed significant variations in UQCRH expression across different diseases:

This differential expression pattern suggests tissue-specific roles for UQCRH in various pathological processes .

What are the optimal applications for UQCRH antibodies in research?

Based on available data, UQCRH antibodies have been validated for several experimental techniques :

When selecting a UQCRH antibody, researchers should consider the specific application and species reactivity requirements. Monoclonal antibodies offer higher specificity, while polyclonal antibodies may provide enhanced sensitivity .

How can I optimize UQCRH detection in immunohistochemistry studies?

For optimal detection of UQCRH in tissue sections:

• Antigen Retrieval: Heat-induced epitope retrieval is recommended using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0).

• Blocking: Use 5-10% normal serum from the same species as the secondary antibody to reduce background.

• Primary Antibody Incubation: Start with manufacturer's recommended dilutions (typically 1:50-1:200) . Incubate overnight at 4°C for optimal sensitivity.

• Controls: Include positive control tissues known to express UQCRH (e.g., normal lung tissue) and negative controls (primary antibody omission) .

• Signal Detection: DAB (3,3'-diaminobenzidine) chromogen typically provides good visualization of UQCRH localization in the mitochondria.

How can UQCRH antibodies be used to study metabolic reprogramming in cancer?

UQCRH plays a significant role in cancer metabolism, particularly in the Warburg effect. Researchers can utilize UQCRH antibodies to:

• Assess Mitochondrial Function: Changes in UQCRH expression correlate with altered oxidative phosphorylation capacity. In ccRCC, UQCRH downregulation promotes the Warburg effect by impairing mitochondrial function .

• Study Metabolic Shifts: Overexpression of UQCRH in KMRC2 (a ccRCC cell line) restored mitochondrial membrane potential, increased oxygen consumption, and attenuated the Warburg effect .

• Investigate Cancer-Specific Mechanisms: In lung adenocarcinoma, increased UQCRH expression correlates with ROS generation, which may contribute to carcinogenesis .

Experimental approach: Researchers can use UQCRH antibodies in combination with Seahorse Extracellular Flux Analyzer measurements to correlate UQCRH expression with mitochondrial respiration parameters such as basal respiration and ATP-linked respiration .

What is the diagnostic potential of UQCRH as a biomarker in lung adenocarcinoma?

UQCRH shows promising potential as a diagnostic biomarker for lung adenocarcinoma:

These parameters indicate that serum UQCRH could serve as a potential non-invasive diagnostic tool for lung adenocarcinoma . Researchers studying cancer biomarkers should consider including UQCRH in their panel of investigated proteins.

How does UQCRH deletion affect mitochondrial complex assembly and function?

Studies using mouse models with homozygous deletion of UQCRH exons (Uqcrh−/−) have revealed several critical insights:

Rescue experiments using lentiviral delivery of wild-type UQCRH demonstrated amelioration of Complex III deficiency, confirming the causative role of UQCRH in these phenotypes .

What are the methodological considerations for studying UQCRH in relation to ROS production?

UQCRH regulates intracellular reactive oxygen species (ROS) production, making it an important target for oxidative stress research . When investigating this relationship:

• ROS Detection Methods:

  • Use fluorescent probes like DCFDA (2′,7′-dichlorofluorescin diacetate) or MitoSOX™ Red for mitochondrial superoxide detection

  • Combine with UQCRH immunostaining to correlate expression with ROS levels

• Experimental Controls:

  • Include positive controls (e.g., H₂O₂ treatment)

  • Use antioxidants (e.g., N-acetylcysteine) to confirm ROS specificity

• Genetic Manipulation Approaches:

  • UQCRH overexpression systems to study rescue effects

  • CRISPR/Cas9-mediated knockout to investigate loss-of-function effects

• Metabolic Parameters to Monitor:

  • Measure extracellular acidification rate (ECAR) for glycolysis assessment

  • Measure oxygen consumption rate (OCR) for mitochondrial respiration

  • Monitor mitochondrial membrane potential using JC-1 or TMRM dyes

How can I address non-specific binding when using UQCRH antibodies?

When encountering non-specific binding:

• Optimize Antibody Concentration: Titrate antibody to find optimal concentration (typically 0.04-0.4 μg/mL for WB, 1:50-1:200 for IHC) .

• Blocking Protocol Enhancement:

  • Increase blocking time (1-2 hours at room temperature)

  • Use alternative blocking agents (BSA, normal serum, commercial blockers)

  • Add 0.1-0.3% Triton X-100 for better penetration in IHC

• Washing Steps:

  • Increase number and duration of washes

  • Use TBS-T (0.1% Tween-20) instead of PBS for reduced background

• Consider Alternative Antibodies:

  • If available, try monoclonal antibodies targeting different epitopes

  • Confirm specificity using knockout/knockdown controls

What are the best approaches to quantify UQCRH expression in tissue samples?

For accurate quantification of UQCRH:

• Western Blot Quantification:

  • Normalize to mitochondrial markers (e.g., VDAC, COX4) rather than total cellular proteins

  • Use fluorescent secondary antibodies for wider linear range

  • Include concentration standards if absolute quantification is needed

• Immunohistochemistry Quantification:

  • Use digital image analysis software (ImageJ, QuPath, etc.)

  • Measure parameters such as intensity, area percentage, and H-score

  • Apply consistent thresholds across all samples

• Flow Cytometry Approaches:

  • Use median fluorescence intensity (MFI) for quantification

  • Include isotype controls to determine background

  • Co-stain with mitochondrial markers to verify localization

How does UQCRH expression correlate with clinical outcomes in different cancers?

The prognostic significance of UQCRH varies across cancer types:

In lung adenocarcinoma, serum UQCRH levels were found to decrease after surgical resection, suggesting its potential utility in monitoring disease progression and treatment response .

For renal cell carcinoma, UQCRH overexpression slowed down tumor growth both in vitro and in vivo, supporting its role as a tumor suppressor in this context .

What methodological approaches can be used to study UQCRH in patient samples?

For clinical research involving UQCRH analysis:

• Serum Analysis:

  • ELISA-based detection with a reported cut-off value of 162.65 pg/ml for lung adenocarcinoma

  • Consider correlating with other established biomarkers (e.g., CEA)

• Tissue Microarray (TMA) Analysis:

  • Use TMAs to efficiently analyze UQCRH expression across multiple patient samples

  • Score staining intensity and percentage of positive cells

  • Correlate with clinical parameters and survival data

• Multi-omics Integration:

  • Combine protein expression (IHC, western blot) with gene expression data

  • Assess methylation status (as hypermethylation can downregulate UQCRH in ccRCC)

  • Correlate with metabolomic profiles to understand functional impact

• Digital Pathology Approaches:

  • Use AI-assisted image analysis for objective quantification

  • Develop algorithms to assess mitochondrial distribution patterns

How can UQCRH be targeted for potential therapeutic interventions?

Based on current understanding, several therapeutic strategies could be explored:

• Epigenetic Modulation: In ccRCC, UQCRH is downregulated due to hypermethylation. Demethylating agents could potentially restore UQCRH expression and mitochondrial function .

• Metabolic Targeting: UQCRH overexpression partially reverses the Warburg effect in ccRCC. Combining UQCRH-targeting strategies with glycolysis inhibitors might enhance anti-cancer effects .

• Gene Therapy Approaches: Lentiviral delivery of wild-type UQCRH has shown promise in ameliorating Complex III deficiency in experimental models, suggesting potential for treating mitochondrial disorders caused by UQCRH mutations .

• ROS Modulation: In cancers where UQCRH is overexpressed (e.g., lung adenocarcinoma), targeting ROS production pathways might be beneficial .

What is known about the interaction between UQCRH and its paralog UQCRHL?

UQCRHL (UQCRH-like) is a paralog of UQCRH with 97% protein sequence identity. Research has revealed:

• Co-expression Pattern: Expression of UQCRH and UQCRHL is tightly correlated in ccRCC, with UQCRHL being the most correlated gene for UQCRH .

• Functional Compensation: Despite high similarity, evidence suggests UQCRHL does not functionally compensate for UQCRH downregulation in clinical samples .

• Research Implications: When designing experiments targeting UQCRH, researchers should consider the potential confounding effects of UQCRHL and use specific antibodies that can distinguish between these highly similar proteins.

• Future Directions: Further investigation into the distinct roles of these paralogs could provide insights into the evolution and specialization of mitochondrial Complex III components.

This correlation suggests a shared regulatory mechanism, but the distinct functional roles of these highly similar proteins remain to be fully elucidated.